Table 6 Comparing the reduction in FVC with the pulmonary system complaints in the study group
FVC ≤ 80% (n = 12) | FVC > 80% (n = 17) | p• | |||
|---|---|---|---|---|---|
n | % | n | % | ||
Coughing | 2 | 16.7 | 4 | 23.5 | 1.000 |
Shortness of breath | 3 | 25.0 | 0 | 0 | 0.060 |
Tachypnea | 0 | 0 | 2 | 11.8 | 0.498 |
Wheezing | 0 | 0 | 1 | 5.9 | 1.000 |
Chest pain | 2 | 16.7 | 2 | 11.8 | 0.706 |
Sputum | 4 | 33.3 | 6 | 35.3 | 0.913 |
Exercise intolerance | 5 | 41.7 | 4 | 23.5 | 0.298 |
Sneezing | 0 | 0 | 2 | 11.8 | 0.498 |
Runny nose | 0 | 0 | 2 | 11.8 | 0.498 |
Nasal congestion | 5 | 41.7 | 8 | 47.1 | 0.774 |